ResearcherManhattan Endoscopy CenterActive in the last 2 years

Gregory Haber

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 4 (principal investigator on 4)
Grants: 0
Labs led: 0
Collaborators: 0

Papers, trials and grants by year

2024: 4 trials

Trials 4

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma Principal investigator NCT06157671 ↗
The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease Principal investigator NCT06276738 ↗
The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) Principal investigator NCT06276764 ↗
The LINFU® U.S. Registry for the in the General Population Without Risk Factors Principal investigator NCT06276803 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.